Neurotech International Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTI.AX research report →
Price Chart
About the company
Neurotech International Limited (NTI. AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies.
- CEO
- Anthony Filippis
- IPO
- 2016
- Employees
- 18
- HQ
- Melbourne, VI, AU
Get TickerSpark's AI analysis on NTI.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.14M
- P/E
- -4.67
- PEG
- -0.05
- P/S
- 6.07
- P/B
- 2.51
- EV/EBITDA
- -0.90
- Div Yield
- 0.00%
- Gross Margin
- 344.17%
- Op Margin
- -145.02%
- Net Margin
- -165.21%
- ROE
- -87.19%
- ROIC
- -25.79%
Latest fiscal year · YoY change
- Revenue
- $2.44M+124422.7%
- Gross Profit
- $2.44M+41763.2%
- Op Income
- $-11,088,225
- Net Income
- $-10,598,859-109.1%
- EPS
- $-0.01-82.1%
- OCF Growth
- -96.4%
- FCF Growth
- -96.4%
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.01
- Beta
- 0.02
- RSI (14)
- 43
- Avg Volume
- 1.84M
No earnings-call transcripts are available for NTI.AX yet.
- Free Float
- 75.0%
- Shares Outstanding
- 1.01B
- Float Shares
- 757.84M
Our NTI.AX coverage
Recent articles, reports, and earnings notes.
No research on NTI.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NTI.AX report →